R
Rainer H. Kohler
Researcher at Harvard University
Publications - 78
Citations - 10790
Rainer H. Kohler is an academic researcher from Harvard University. The author has contributed to research in topics: In vivo & Immunotherapy. The author has an hindex of 41, co-authored 70 publications receiving 8881 citations. Previous affiliations of Rainer H. Kohler include Cornell University & University of Giessen.
Papers
More filters
Journal ArticleDOI
Identification of splenic reservoir monocytes and their deployment to inflammatory sites
Filip K. Swirski,Matthias Nahrendorf,Martin Etzrodt,Martin Etzrodt,Moritz Wildgruber,Virna Cortez-Retamozo,Peter Panizzi,Jose-Luiz Figueiredo,Rainer H. Kohler,Aleksey Chudnovskiy,Peter Waterman,Elena Aikawa,Thorsten R. Mempel,Peter Libby,Ralph Weissleder,Mikael J. Pittet +15 more
TL;DR: It is shown that bona fide undifferentiated monocytes reside in the spleen and outnumber their equivalents in circulation and identifies splenic monocytes as a resource that the body exploits to regulate inflammation.
Journal ArticleDOI
Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo
Elena Aikawa,Matthias Nahrendorf,Jose-Luiz Figueiredo,Filip K. Swirski,Timur Shtatland,Rainer H. Kohler,Farouc A. Jaffer,Masanori Aikawa,Ralph Weissleder +8 more
TL;DR: This serial in vivo study demonstrates the real-time association of macrophage burden with osteogenic activity in early-stage atherosclerosis and offers a cellular-resolution tool to identify preclinical microcalcifications.
Journal ArticleDOI
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
Christopher B. Rodell,Sean P. Arlauckas,Michael F. Cuccarese,Christopher Garris,Ran Li,Maaz S. Ahmed,Rainer H. Kohler,Mikael J. Pittet,Ralph Weissleder +8 more
TL;DR: The ability of rationally engineered drug–nanoparticle combinations to efficiently modulate tumour-associated macrophages for cancer immunotherapy is demonstrated and R848, an agonist of the toll-like receptors TLR7 and TLR8 identified in a morphometric-based screen, is a potent driver of the M1 phenotype in vitro.
Journal ArticleDOI
Exchange of Protein Molecules Through Connections Between Higher Plant Plastids
TL;DR: In transgenic plants in which the plastid stroma was labeled with green fluorescent protein (GFP), thin tubular projections emanated from individual plastids and sometimes connected to other plasts, which allow the exchange of molecules within an interplastid communication system, which may facilitate the coordination of plasts activities.
Journal ArticleDOI
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Christopher Garris,Sean P. Arlauckas,Rainer H. Kohler,Marcel P. Trefny,Seth B. Garren,Cecile Piot,Camilla Engblom,Christina Pfirschke,Marie Siwicki,Jeremy Gungabeesoon,Gordon J. Freeman,Sarah Warren,SuFey Ong,Erica Browning,Christopher G. Twitty,Robert H. Pierce,Mai H. Le,Alain Algazi,Adil Daud,Sara I. Pai,Alfred Zippelius,Ralph Weissleder,Mikael J. Pittet +22 more
TL;DR: It is found that activating the non‐canonical NF‐&kgr;B transcription factor pathway amplified IL‐12‐producing DCs and sensitized tumors to anti‐PD‐1 treatment, suggesting a therapeutic strategy to improve responses to checkpoint blockade.